Advertisement
Screener

Broadfin Capital, LLC Historic Quarter Change: USA Everything Else, New

Broadfin Capital, LLC historic quarter change: USA Everything Else, New

In partnership units, exchange-traded notes and anything else (listed in the US), over 13 quarters from 2013-06-30 to 2016-09-30, Broadfin Capital, LLC opened 3 positions, added to 0, reduced 0 and sold out of 3.

  • Q2 2016: Stock EGALET CORP; Country of operation —; Class NOTE 5.500 4/0; Shares before 0.
  • Q2 2016: Stock PERNIX THERAPEUTICS HLDGS IN; Country of operation —; Class DBCV 4.250% 4/0; Shares before 0.
  • Q2 2015: Stock PERNIX THERAPEUTICS HLDGS IN; Country of operation —; Class DEBT 4.250% 4/0; Shares before 0.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1511901), 13 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-15); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-16); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-17); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-28); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2010-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q2 2016EGALET CORP
CUSIP 28226BAB0
NOTE 5.500 4/0010,000,000+10,000,000$0$7,600,000+$7,600,0002016-08-15
Q2 2016PERNIX THERAPEUTICS HLDGS IN
CUSIP 71426VAK4
DBCV 4.250% 4/0015,500,000+15,500,000$0$3,565,000+$3,565,0002016-08-15
Q2 2015PERNIX THERAPEUTICS HLDGS IN
CUSIP 71426VAJ7
DEBT 4.250% 4/0015,500,000+15,500,000$0$13,837,000+$13,837,0002015-08-14

Similar Firms

Firm NameCountry13F ValueHoldings
Not available yet